Cutaneous atrophy after corticosteroid injection.
Soft tissue inflammatory disorders can be treated by regional administration of corticosteroid preparations. However, the local catabolic effects of these agents can result in cutaneous atrophy and pigmentary changes. Since all injectable steroid agents may produce these adverse effects, corticosteroids must be used judiciously. The physician must be familiar with the chosen steroid and its recommended dosage.
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects*; D000328:Adult; D001284:Atrophy; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage / Q000009:adverse effects; D007279:Injections, Subcutaneous; D008775:Methylprednisolone / Q000008:administration & dosage / Q000009:adverse effects; D008875:Middle Aged; D010859:Pigmentation Disorders / Q000139:chemically induced; D012867:Skin / Q000473:pathology*
D000305:Adrenal Cortex Hormones; D006854:Hydrocortisone; D008775:Methylprednisolone